Telehealth — Sep 14 – Sep 18, 2026 (Wk 38): Telehealth Sector Sees Mixed Earnings, AI Focus, and Steadying Stocks

September 20, 2026 · · 8 min read
Weekly theme roundup · Sep 14 – Sep 18, 2026
Covering the 14 Telehealth stocks in our database — browse every Telehealth name →

TL;DR — This week, several telehealth companies reported earnings, with some missing expectations while others saw their stock prices stabilize or edge higher. The broader market showed increased investor interest in US stocks, with a continued focus on AI's potential impact across various sectors, including healthcare.

Theme risk
43/100 Elevated
▲ +3 vs last week
Median price / model value
1.02×
roughly fairly priced · 14 stocks
Insider tape (CMP-filtered)
0 buys
open-market, routine & 10b5-1 stripped

What moved

  • Teladoc Health (TDOC) reported lower-than-expected earnings and provided a reduced outlook, which could indicate ongoing challenges in the telehealth market or specific operational issues for the company. This performance raises questions about the valuation of its stock. [simplywall.st]
  • American Well (AMWL) stock stabilized after its recent financial results, suggesting that while the overall outlook for telehealth remains mixed, the market may be finding a baseline for the company's valuation following its performance. [AD HOC NEWS]
  • LifeMD Inc. (LFMD) experienced a wider-than-expected loss in Q2 2026, yet its shares edged higher. This suggests that investors may be looking past short-term losses, potentially focusing on other aspects of the company's operating income trends or future prospects. [dars.gov.et]
  • AT&T's collaboration with LifeMD for virtual healthcare services could be a significant development for LifeMD, potentially expanding its reach and validating its service model through a partnership with a major telecommunications provider. This could impact LifeMD's growth trajectory. [TradingView]
  • Hims & Hers (HIMS) is under scrutiny due to an FTC privacy lawsuit. The outcome of this legal challenge could influence investor confidence and the company's operational practices, potentially affecting its long-term 'bull case' if privacy regulations become more stringent or costly to comply with. [simplywall.st]
  • Insmed (IMSR) saw a premarket drop, but retail investors reportedly view it as a long-term 'sleeper' stock. This indicates a potential divergence between short-term market reactions and longer-term investor sentiment, possibly due to underlying fundamentals or future growth expectations. [Stocktwits]

The why behind the week

  • The mixed earnings reports from telehealth companies like Teladoc and LifeMD, alongside the stabilization of American Well, reflect a sector that is still finding its footing. While some companies face headwinds, others may be demonstrating resilience or attracting investor interest based on specific partnerships or perceived long-term value. [simplywall.st] [AD HOC NEWS] [dars.gov.et] [TradingView]
  • The broader market saw investors buying US stocks at the fastest pace in three months, indicating a general increase in market confidence. This positive sentiment can provide a more favorable environment for telehealth stocks, even those facing individual challenges, as capital flows into the market. [US News Money]
  • The continued focus on AI hyperscaler earnings and discussions around AI spending, as highlighted by Jim Cramer's interaction with OpenAI's CFO, suggest that AI remains a significant theme for investors. For telehealth, AI could play a role in improving diagnostics, patient management, and operational efficiency, making it a key area for future development and investment. [Stocktwits] [24/7 Wall St.]
  • Amazon's CEO Andy Jassy made a prediction, though the specific content is not detailed in our sources. Given Amazon's existing presence in healthcare, any significant prediction from its leadership could signal potential shifts or opportunities within the broader health tech landscape, including telehealth. [The Globe and Mail]
  • The Telehealth theme's risk score increased to 43/100 (Elevated), up 3 points from last week. This indicates a slightly higher perceived risk for the sector, which could be influenced by factors such as mixed earnings, regulatory scrutiny, or broader market volatility. [SAVNG data]

📄 Filings that matter (8-Ks, straight from EDGAR)

The macro backdrop

10-yr Treasury 4.94%Expected inflation 2.3%VIX 14.8High-yield spread 2.70%Yield curve (10y–2y) 0.25%Overall market risk 44/100 Elevated
How to read it
  • Credit Spread: tight — credit markets are relaxed, no stress being priced
  • Yield Curve: flat — the recession-warning zone; a rapid steepening from here has often preceded the actual downturn
  • Vix: calm — the market is complacent, which cuts both ways (little cushion if news turns)

Every theme swims in this tide — judge the week’s moves against it.

📅 On the calendar — and why it matters here

  • Sun Sep 20 — FOMC (Fed rate decision / minutes). the single biggest scheduled market mover — a rate surprise in either direction repriced everything, hardest on rate-sensitive names (growth, REITs, utilities, homebuilders). Watch for a surprise vs expectations — that gap, not the number itself, is what moves markets.
  • Tue Sep 29 — JOLTS (job openings). labor-market tightness — a cooling read eases wage-inflation fears. Watch for a surprise vs expectations — that gap, not the number itself, is what moves markets.
  • Wed Sep 30 — GDP. the broadest growth read — confirms or breaks the soft-landing thesis. Watch for a surprise vs expectations — that gap, not the number itself, is what moves markets.
  • Wed Sep 30 — PCE inflation (the Fed's gauge). a hot print pushes rate-cut odds out (pressuring long-duration assets); a soft print does the reverse — one of the highest-impact releases. Watch for a surprise vs expectations — that gap, not the number itself, is what moves markets.
  • Fri Oct 2 — Jobs report (payrolls + unemployment). sets the growth-vs-recession narrative — a weak number lifts recession odds (hits cyclicals, consumer, financials); a strong one can paradoxically pressure rates. Watch for a surprise vs expectations — that gap, not the number itself, is what moves markets.

What to watch next

  • The 10-year Treasury yield at 4.94% and a high-yield credit spread of 2.7% are important for telehealth companies as they influence the cost of capital. Higher rates can make it more expensive for companies to borrow for expansion or operations, potentially impacting growth and profitability. [macro data]
  • The VIX at 14.81 indicates relatively low market volatility. A stable market environment can provide a more predictable backdrop for telehealth stocks, as extreme market swings can disproportionately affect growth-oriented sectors. [macro data]
  • The Shiller CAPE ratio at 40.94 suggests that the broader market is trading at a high valuation relative to historical earnings. While not specific to telehealth, a high CAPE can imply that investors are paying a premium for future growth, which could benefit or challenge growth sectors like telehealth depending on their perceived potential. [macro data]
  • The market risk score of 44/100, combined with the elevated risk score for the Telehealth theme (43/100), indicates that while the overall market has moderate risk, the telehealth sector faces similar or slightly higher perceived risks. This suggests investors may be evaluating these stocks with caution. [macro data] [SAVNG data]
  • The median price-to-model-value across 14 telehealth stocks is 1.02x. This suggests that, on average, these stocks are trading close to their intrinsic value according to SAVNG's models. This metric can help investors gauge whether the sector is generally over or undervalued. [SAVNG data]

This week’s headlines (sources)

Every claim above cites its source — headlines link to the original outlet; [SAVNG data] marks our own EDGAR-computed figures. Where our sources don’t explain a move, we say so rather than guess. All weekly roundups →

SAVNG is an educational research publication, not a Registered Investment Adviser. Everything here is general-circulation information produced by an automated pipeline — the same for every reader — and is not personalized investment advice, an offer, or a recommendation to buy or sell any security. Any performance figure is hypothetical; past performance does not predict future results. Details.

Get next week's roundup automatically

Get these in any reader — no email, no account. Paste a link into Feedly, Inoreader, NetNewsWire, or your browser.